Species-specific inhibitor sensitivity of angiotensin-converting enzyme 2 (ACE2) and its implication for ACE2 activity assays
Open Access
- 1 November 2011
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 301 (5), R1293-R1299
- https://doi.org/10.1152/ajpregu.00339.2011
Abstract
Angiotensin-converting enzyme 2 (ACE2) is a component of the renin-angiotensin system, and its expression and activity have been shown to be reduced in cardiovascular diseases. Enzymatic activity of ACE2 is commonly measured by hydrolysis of quenched fluorescent substrates in the absence or presence of an ACE2-specific inhibitor, such as the commercially available inhibitor DX600. Whereas recombinant human ACE2 is readily detected in mouse tissues using 1 μM DX600 at pH 7.5, the endogenous ACE2 activity in mouse tissues is barely detectable. We compared human, mouse, and rat ACE2 overexpressed in cell lines for their sensitivity to inhibition by DX600. ACE2 from all three species could be inhibited by DX600, but the half maximal inhibitory concentration (IC50) for human ACE2 was much lower (78-fold) than for rodent ACE2. Following optimization of pH, substrate concentration, and antagonist concentration, rat and mouse ACE2 expressed in a cell line could be accurately quantified with 10 μM DX600 (>95% inhibition) but not with 1 μM DX600 (<75% inhibition). Validation that the optimized method robustly quantifies ACE2 in mouse tissues (kidney, brain, heart, and plasma) was performed using wild-type and ACE2 knockout mice. This study provides a reliable method for measuring human, as well as endogenous ACE2 activity in rodents. Our data underscore the importance of validating the effect of DX600 on ACE2 from each particular species at the experimental conditions employed.Keywords
This publication has 31 references indexed in Scilit:
- ACE2/ANG-(1–7)/Mas pathway in the brain: the axis of goodAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2011
- Blood pressure and renal hemodynamic effects of angiotensin fragmentsHypertension Research, 2011
- Reciprocal changes in renal ACE/ANG II and ACE2/ANG 1–7 are associated with enhanced collecting duct renin in Goldblatt hypertensive ratsAmerican Journal of Physiology-Renal Physiology, 2011
- Characterization of angiotensin-converting enzymes 1 and 2 in the soleus and plantaris muscles of ratsBrazilian Journal of Medical and Biological Research, 2010
- Angiotensin-Converting Enzyme 2 Overexpression in the Subfornical Organ Prevents the Angiotensin II–Mediated Pressor and Drinking Responses and Is Associated With Angiotensin II Type 1 Receptor DownregulationCirculation Research, 2008
- ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHRPhysiological Genomics, 2006
- Protection from angiotensin II‐induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in ratsExperimental Physiology, 2005
- Cloning and characterization of a secreted form of angiotensin-converting enzyme 2Regulatory Peptides, 2004
- Novel Peptide Inhibitors of Angiotensin-converting Enzyme 2Published by Elsevier BV ,2003
- Renal Interstitial Fluid Angiotensin I and Angiotensin II Concentrations during Local Angiotensin-Converting Enzyme InhibitionJournal of the American Society of Nephrology, 2002